[1] Yuan R, Lin Y. Traditional Chinese medicine: an approach to scientific proof and clinical validation. Pharmacol Ther. 2000; 86(2): 191-198.
[2] Patwardhan B, Mashelkar RA. Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward? Drug Discov Today. 2009; 14(15): 804-811.
[3] World Health Organization. WHO publishes list of top emerging diseases likely to cause major epidemics. Geneva: World Health Organization, 2015.
[4] Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug discovery. Environ Health Perspect. 2001; 109(1): 69-75.
[5] Azadbakht M, Hosseini AS, Fakhri M. Necessity of standardization of medicinal plant extracts in investigations and the manner to perform it. Razi J Med Sci. 2017; 23(152): 8-17.
[6] Mirzaee F, Hosseini A, Jouybari HB, Davoodi A, Azadbakht M. Medicinal, biological and phytochemical properties of Gentiana species. J Tradit Complement Med. 2017; 7(4): 400-408.
[7] Davoodi A, Ebrahimzadeh MA, Fathalinezhad F, Khoshvishkaie E. Antibacterial activity of Mespilus germanica leaf extract. J Mazandaran Univ Med Sci. 2017; 26(146): 173-178.
[8] Patwardhan B, Warude D, Pushpangadan P, Bhatt N. Ayurveda and traditional Chinese medicine: a comparative overview. Evid Based Complement Alternat Med. 2005; 2(4): 465-473.
[9] Fakhri M, Davoodi A, Parviz M, Ghadi ZS, Mousavinasab SN, Farhadi R, Azadbakht M. Characterization and HPLC analysis of manna from some Cotoneaster species. Int J Pharm Sci Res. 2017; 8(12): 5360-5366.
[10] Blondeau S, Do Q, Scior T, Bernard P, Morin-Allory L. Reverse pharmacognosy: another way to harness the generosity of nature. Curr Pharm Des. 2010; 16(15): 1682-1696.
[11] Do QT, Bernard P. Reverse pharmacognosy: a new concept for accelerating natural drug discovery. Adv Phyt. 2006; 2(1): 1-20.
[12] Le Tourneau C, Stathis A, Vidal L, Moore MJ, Siu LL. Choice of starting dose for molecularly targeted agents evaluated in first-in-human phase I cancer clinical trials. J Clin Oncol. 2010; 28(8): 1401-1407.
[13] Hosseini A, Azadbakht M, Yousofpoor M. ‘Maoljobon’ a drug in Iranian traditional medicine. J Mazandaran Univ Med Sci. 2017; 26(146): 269-278.
[14] Aghili Khorasani M. Makhzan ol Advieh. Tehran: Tehran University of Medical Sciences Press, 2009.
[15] Freireich EJ, Gehan E, Rall D, Schmidt L, Skipper H. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chem Rep. 1966; 50(4): 219-225.
[16] Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. Fed Am Soc Exp Biol J. 2008; 22(3): 659-661.
[17] Food & Drug Administration. Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers. Rockville: Food & Drug Administration, 2005.